AHCO vs SPOK
AHCO: AdaptHealth is a leading provider of healthcare-at-home solutions, including sleep, respiratory, and wellness equipment and services, for patients navigating complex chronic conditions. SPOK: Spok provides enterprise-grade clinical communication and collaboration software alongside a legacy paging network for hospitals and public safety organizations.
Side-by-side fundamentals
| Metric | AHCO | SPOK | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $5.81 | $11.99 | |
| Market cap | $792M | $251M | |
| P/E as of 2026-10-30 | n/a | 13.63 | |
| Net margin FY2025, SEC XBRL | -2.2% | +11.4% | SPOK higher |
| Operating margin FY2025, SEC XBRL | +2.8% | +14.1% | SPOK higher |
| ROE FY2025, SEC XBRL | -4.7% | +10.8% | SPOK higher |
| ROA FY2025, SEC XBRL | -1.6% | +7.7% | SPOK higher |
| Debt / equity | 1.37 | 0.00 | SPOK lower |
| Revenue growth (YoY) FY2025, SEC XBRL | -0.5% | +1.5% | SPOK higher |
| Revenue CAGR (3y) SEC XBRL | +3.0% | +1.3% | AHCO higher |
| Dividend yield as of 2026-09-02 | n/a | 10.34% | |
| Dividend streak (yrs) SEC XBRL | 0 | 9 | SPOK higher |
| Beta as of 2026-09-03 | 0.68 | 0.28 | |
| 1-year return as of 2026-10-30 close | -35.1% | -13.3% | SPOK higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.